|
Characteristics
|
Group I (ESCC patient specimens)
|
Group II (non-tumor vs. tumor)
|
|---|
|
Patients no
|
68
|
68
|
|
Age (years)
| | |
|
Median age
|
57
|
57
|
|
Range
|
36–87
|
34–82
|
|
Sex
| | |
|
Male/female
|
64/4
|
65/3
|
|
Tumor stages
| | |
|
I
|
8
|
6
|
|
II
|
19
|
14
|
|
III
|
31
|
43
|
|
IV
|
10
|
5
|
|
Two-year survival
| | |
|
≥ 24 months
|
32
|
18
|
|
< 24 months
|
36
|
50
|
- Group I is the characteristics of ESCC patients for measuring the miR-146a RNA expression levels by real-time RT-PCR
- Group II is the characteristics of ESCC patient specimens (non-tumor vs. tumor) for direct detection of miR-146a and vimentin expression levels by ISH and IHC staining
